AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.
Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R.
Collina F, et al. Among authors: la mantia e, la sala l.
Cancers (Basel). 2019 Jun 7;11(6):785. doi: 10.3390/cancers11060785.
Cancers (Basel). 2019.
PMID: 31181609
Free PMC article.